MedTrace Logo

Intravenous Ibuprofen Versus Ketorolac in Bariatric Surgery

NCT05801900 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 116

Last updated 2023-04-06

No results posted yet for this study

Summary

The aim of the current study is to compare the analgesic effects of both drugs in patients with obesity undergoing bariatric surgery.

Conditions

  • Postoperative Pain
  • Bariatric Surgery Candidate

Interventions

DRUG

Ketorolac group

30 min preoperatively then every 8 hours postoperatively

DRUG

Ibuprofen group

30 min preoperatively then every 8 hours postoperatively

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-30
Primary Completion
2023-06-30
Completion
2023-06-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05801900 on ClinicalTrials.gov